Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about RA: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
RA is a concept in neurodegeneration research. Key relationships include: implicated in, associated with. Connected to 158 entities in the SciDEX knowledge graph.
AI-generated illustration · click image to enlarge
Regenerate portrait ↻| Name | RA |
| Key Genes/Proteins | A2M, ABCA1, ABCB1, ABCG1, ACTB, AGER |
| Linked Hypotheses | 18 hypotheses |
Knowledge base pages for this entity
graph TD
RA["RA"]
MAP1B["MAP1B"] -->|"implicated in"| RA
MAP2["MAP2"] -->|"implicated in"| RA
MAP6["MAP6"] -->|"implicated in"| RA
GLUT4["GLUT4"] -->|"implicated in"| RA
PPAR["PPAR"] -->|"implicated in"| RA
RAB7A["RAB7A"] -->|"implicated in"| RA
LRP2["LRP2"] -->|"implicated in"| RA
ACTB["ACTB"] -->|"implicated in"| RA
CTSD["CTSD"] -->|"implicated in"| RA
ATG["ATG"] -->|"implicated in"| RA| Target | Relation | Type | Str |
|---|---|---|---|
| No outgoing edges | |||
| Source | Relation | Type | Str |
|---|---|---|---|
| RBP | associated_with | protein | 0.56 |
| IDH2 | implicated_in | gene | 0.50 |
| IDH1 | implicated_in | gene | 0.50 |
| SLC16A2 | implicated_in | gene | 0.50 |
| SLC16A1 | implicated_in | gene | 0.50 |
| GBM | implicated_in | gene | 0.50 |
| C1QA | implicated_in | gene | 0.50 |
| C1QC | implicated_in | gene | 0.50 |
| C1Q | implicated_in | gene | 0.50 |
| SPI1 | implicated_in | gene | 0.50 |
| UNC5B | implicated_in | gene | 0.50 |
| NTN1 | implicated_in | gene | 0.50 |
| GPNMB | implicated_in | gene | 0.50 |
| NPTX2 | implicated_in | gene | 0.50 |
| VGF | implicated_in | gene | 0.50 |
| PTN | implicated_in | gene | 0.50 |
| NTN3 | implicated_in | gene | 0.50 |
| TARDBP | implicated_in | gene | 0.50 |
| SNRNP70 | implicated_in | gene | 0.50 |
| AGER | implicated_in | gene | 0.50 |
| HSPA1A | implicated_in | gene | 0.50 |
| HSPA1B | implicated_in | gene | 0.50 |
| ERK1 | implicated_in | gene | 0.50 |
| JNK | implicated_in | gene | 0.50 |
| STING | implicated_in | gene | 0.50 |
| IRF3 | implicated_in | gene | 0.50 |
| IFN | implicated_in | gene | 0.50 |
| DOT1L | implicated_in | gene | 0.50 |
| PLCG2 | implicated_in | gene | 0.50 |
| ABCB1 | implicated_in | gene | 0.50 |
| PRMT5 | implicated_in | gene | 0.50 |
| PRMT1 | implicated_in | gene | 0.50 |
| PHGDH | implicated_in | gene | 0.50 |
| FASN | implicated_in | gene | 0.50 |
| EGR1 | implicated_in | gene | 0.50 |
| KRAS | implicated_in | gene | 0.50 |
| G3BP1 | implicated_in | gene | 0.50 |
| ALS | implicated_in | gene | 0.50 |
| TOLLIP | implicated_in | gene | 0.50 |
| NBR1 | implicated_in | gene | 0.50 |
| FUS | implicated_in | gene | 0.50 |
| TRIM21 | implicated_in | gene | 0.50 |
| OPTN | implicated_in | gene | 0.50 |
| NDP52 | implicated_in | gene | 0.50 |
| BECN1 | implicated_in | gene | 0.50 |
| TAX1BP1 | implicated_in | gene | 0.50 |
| GFP | implicated_in | gene | 0.50 |
| SMCR8 | implicated_in | gene | 0.50 |
| VCP | implicated_in | gene | 0.50 |
| GSS | implicated_in | gene | 0.50 |
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
neuropharmacology | 2026-04-25 | 4 hypotheses Top: 0.659
neurodegeneration | 2026-04-24 | 5 hypotheses Top: 0.790
neurodegeneration | 2026-04-23 | 7 hypotheses Top: 0.780
neurodegeneration | 2026-04-16 | 1 hypotheses Top: 0.577
neurodegeneration | 2026-04-14 | 0 hypotheses
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| Plant-based dietary patterns and Alzheimer's disease risk in multiethn | clinical | Alzheimer's disease and relate | 0.950 | 0.00 | human patients | proposed | N/A |
| Tet2 modulation in Aβ42-injured mouse hippocampal neurons | exploratory | Alzheimer's disease | 0.900 | 0.00 | primary mouse hippocampal neur | proposed | N/A |
| iPSC-NPC effects on astrocytes in vitro ICH model | exploratory | intracerebral hemorrhage | 0.900 | 0.00 | in vitro ICH cell culture mode | completed | N/A |
| AMPK knockdown validation experiment | exploratory | intracerebral hemorrhage | 0.880 | 0.00 | astrocyte cell culture | proposed | N/A |
| P2RY12-MTOR pathway interaction in VSMCs | exploratory | atherosclerosis | 0.850 | 0.00 | cultured VSMCs | proposed | N/A |
| iPSC-NPC transplantation in ICH animal model | validation | intracerebral hemorrhage | 0.850 | 0.00 | animal ICH model | proposed | N/A |
| Brain Connectivity-Targeted tACS Trial in Early AD | clinical | Alzheimer's Disease | 0.509 | 0.50 | human postmortem brain tissue | proposed | $520,000 |
| s:** - Test whether HCN1 knockout specifically in EC layer II accelera | falsification | Alzheimer's Disease | 0.400 | 0.50 | cell_line | proposed | $80,000 |
| AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Positive Indiv | clinical | Alzheimer's Disease | 0.400 | 0.50 | human | proposed | $6,550,000 |
| AD Combination Therapy Trial: Anti-Aβ + Anti-Tau | clinical | Alzheimer's Disease | 0.400 | 0.50 | cell_line | proposed | $180,000 |
| Biomarker-Guided Sequential Therapy Selection in Alzheimer's Disease | clinical | Alzheimer's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
| tACS Connectivity Trial in Early Alzheimer's | clinical | Alzheimer's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
| Brain Connectivity-Targeted tACS Trial in Early AD | clinical | Alzheimer's Disease | 0.400 | 0.50 | mouse | proposed | $730,000 |
| Cognitive Reserve Mechanisms in Alzheimer's Disease — Molecular Basis | clinical | Alzheimer's Disease | 0.400 | 0.50 | human | completed | $6,550,000 |
| Cholinergic System Dysfunction in DLB — Mechanisms and Therapeutic Res | clinical | Alzheimer's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Complement C1q/C3-CR3 signaling pathway mediates abnormal microglial phagocytosi [PMID:38642614] | Han QQ, Shen SY, Liang LF, Chen XR, Yu J | Brain Behav Immun | 2024 | 1 |
| Metabolic orchestration of cell death by AMPK-mediated phosphorylation of RIPK1. [PMID:37384704] | Zhang T, Xu D, Trefts E, Lv M, Inuzuka H | Science | 2023 | 1 |
| Replating Induces mTOR-Dependent Rescue of Protein Synthesis in Charcot-Marie-To [PMID:41876253] | Koenig J, McGuire A, Homedan Y, Alberhas | eNeuro | 2026 | 0 |
| S-equol promotes ferroptosis in triple negative breast cancer by coordinating NC [PMID:41925800] | Ni F, Huang Z, Cui Y, Huang P, Xue Z, Hu | Molecular and cellular biochem | 2026 | 0 |
| Anatomical and neurochemical profiles of somatostatin-positive neurons in the mo [PMID:41796787] | Tomioka R, Kobayashi K, Song WJ | Neuroscience | 2026 | 0 |
| Subtype-Specific Roles of Anterior Cingulate Cortex Neurons in Pain-Induced Soci [PMID:41799202] | Wan X, Yan Z, Zhang Z, Liu X, Yang D, Zh | Theranostics | 2026 | 0 |
| Metabolic dysregulation reshapes the immune landscape: The gut microbiota-mTOR a [PMID:41445190] | Li J, Li J, Chen K | Mol Ther | 2026 | 0 |
| Senecavirus a VP2 protein orchestrates PRDX1 degradation through dual autophagy [PMID:41479169] | Li Z, Yang X, Mao J, Zeng P, Qi Y et al. | Autophagy | 2026 | 0 |
| Inhibition of mTOR Enhances the Efficacy of Proteasome-Dependent Targeted Protei [PMID:41529091] | Liu Y, Sun Y, Song TY, Ni SY, Pu YS et a | Cancer Res | 2026 | 0 |
| Microglial metabolic reprogramming in Alzheimer's disease: Pathways, mechanisms, [PMID:41651180] | Yang FG, Yang H, Han SW, Wang JT, Gao W | Ageing Res Rev | 2026 | 0 |
| mTOR signaling pathway in primary Sjögren's syndrome: Pathogenesis and potential [PMID:41789635] | Huo R, Yang Y, Wei C, Yang Y, Meng D et | Int J Mol Med | 2026 | 0 |
| Microcystin-LR-induced phosphorylation imbalance and organelle stress: An integr [PMID:41846138] | Teng Z, Shahzad A, Xu Z, Xia J, Zhang J | J Hazard Mater | 2026 | 0 |
| Copper deficiency impairs oligodendrocyte maturation and social behavior via mit [PMID:41920999] | Usui N, Doi M, Berto S, Matsuoka K, Ishi | Sci Adv | 2026 | 0 |
| A comparative analysis of pig-to-rhesus corneal xenotransplantation with various [PMID:41928466] | Lee SH, Yoon CH, Choi HJ, Lee HJ, Kang H | Korean J Ophthalmol | 2026 | 0 |
| Crosstalk between inflammation and autophagy in CeD organoids. [PMID:41933042] | Bellomo C, Furone F, Auricchio R, D'Anie | Sci Rep | 2026 | 0 |
| Epigenetically regulated pancreatic GABA-somatostatin signaling underlies gestat [PMID:41779871] | Zhu H, Luo S, Liu C, Cheng Y, Ren Z, Mo | Science translational medicine | 2026 | 0 |
| Therapeutic Potential of Somatostatin and Its Analogues in Alzheimer's Disease: [PMID:41854733] | Liu K, Zhang XY, Wang YT, Wang R, Jin RH | Molecular neurobiology | 2026 | 0 |
| Targeting the AKT/mTOR axis: pectolinarigenin induces autophagy and apoptosis in [PMID:41924135] | Fang Y, Bai J, Bo S, Cui X, Song H, Guo | Frontiers in pharmacology | 2026 | 0 |
| Targeting the GSK-3β/mTOR axis: a novel pharmacological strategy for preeclampsi [PMID:41922823] | Alshaikh ABA, Al-Kuraishy HM, Abdelaziz | Naunyn-Schmiedeberg's archives | 2026 | 0 |
| Platelet proteomic signatures of amyloid β-positive mild cognitive impairment an [PMID:41904574] | Cho YE, Kim A, Lee HM, Oh JW, Son SJ, Ro | Molecular brain | 2026 | 0 |
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.80 · 2026-04-26
closed · Rounds: 4 · Score: 0.50 · 2026-04-26
closed · Rounds: 4 · Score: 0.66 · 2026-04-25
closed · Rounds: 4 · Score: 0.74 · 2026-04-24
closed · Rounds: 4 · Score: 0.76 · 2026-04-16
closed · Rounds: 4 · Score: 0.95 · 2026-04-16
Hypotheses and analyses mentioning RA in their description or question text
Score: 0.895 · Alzheimer's disease · 2026-04-02
## Mechanistic Overview Gamma entrainment therapy to restore hippocampal-cortical synchrony starts from the claim that m
Score: 0.892 · neurodegeneration · 2026-04-07
## Mechanistic Overview TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegeneration starts from the claim that mod
Score: 0.887 · neurodegeneration · 2026-04-16
## Mechanistic Overview Optimized Temporal Window for Metabolic Boosting Therapy Determines Success of Microglial State
Score: 0.877 · neurodegeneration · 2026-04-02
## Mechanistic Overview APOE-Dependent Autophagy Restoration starts from the claim that modulating MTOR within the disea
Score: 0.865 · Alzheimer's disease · 2026-04-07
## Mechanistic Overview Optogenetic restoration of hippocampal gamma oscillations via selective PV interneuron activatio
Score: 0.865 · molecular neurobiology · 2026-04-17
## Mechanistic Overview Gamma Oscillation Entrainment Enhances lncRNA-9969-Mediated Autophagy Through PV Interneuron-Spe
Score: 0.865 · neuroscience · 2026-04-07
## Mechanistic Overview Glymphatic-Mediated Tau Clearance Dysfunction starts from the claim that modulating MAPT within
Score: 0.863 · Alzheimer's disease · 2026-04-07
## Mechanistic Overview Closed-loop focused ultrasound targeting EC-II PV interneurons to restore theta-gamma coupling a
Score: 0.862 · neurodegeneration · 2026-04-16
## Mechanistic Overview TREM2 R47H Variant-Driven Metabolic Dysfunction as the Primary Trigger for Failed DAM Transition
Score: 0.861 · neuroscience · 2026-04-12
## Mechanistic Overview TREM2-Mediated Microglial Dysfunction Disrupts Perivascular Tau Clearance starts from the claim
Score: 0.860 · neurodegeneration · 2026-04-02
## Mechanistic Overview Circadian Glymphatic Entrainment via Targeted Orexin Receptor Modulation starts from the claim t
Score: 0.856 · neurodegeneration · 2026-04-22
## Mechanistic Overview H6: Aberrant eIF2α Phosphorylation Creates Stalled Translation State starts from the claim that